Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Serum and CSF Correlation in Neurosurgery Patients
NCT04118829Phase 4Unknown
- Sponsor
- Carilion Clinic
- Start
- Nov 2019
- Primary completion
- Sep 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of perampanel in epilepsy (2 arms), sponsored by Carilion Clinic. Primary endpoint: Blood brain barrier serum at 3 weeks. Status: unknown.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04118829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118829.